NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

The Cognate contract for manufacturing is in the SEC docs (though many numbers are of course redacted).

The Advent contract for manufacturing at London is the same per SEC docs. They paid an initial $1m to "transfer the tech" from Cognate to Advent (which of course was Cognate). And since then about $5M a year to reserve capacity. Contract runs through end of '22 but they can cancel for $5M.

BTW that is the answer to an earlier question on rev vs cost for Specials. Cost is about $5M/year for revenue that peaked at $2.4M/y.

For Sawston, the current contract is cost plus 15% and runs until June '22.

I am 100% certain that LP and LP have a handshake deal on what happens after that. But unlike actual contracts between relayed parties (which must be disclosed), conversations within a single individual's brain need not be.